DOCSLIB.ORG

Immunology Research: Challenges and Opportunities in a Time of Budgetary Constraint

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Immunology Research: Challenges and Opportunities in a Time of Budgetary Constraint COMMENTARY Immunology research: challenges and opportunities in a time of budgetary constraint Charles J Hackett, Daniel Rotrosen, Hugh Auchincloss & Anthony S Fauci There have been enormous advances in the field of immunology over the past 3 decades, and those advances have had a positive effect on many subspecialties of medicine. Opportunities for even more notable advances remain. http://www.nature.com/natureimmunology However, present and projected budget constraints for the National Institutes of Health have created formidable challenges. This commentary addresses the opportunities and challenges for the field of immunology during a period of restricted budgets. any of the world’s major diseases— the 27 NIH institutes and centers fund research $3.7B $4.4B Minfection, cancer, autoimmunity and and training grants on immunology, attesting allergy—critically involve the immune system. to the fundamental importance of immuno- $1.6B Continued progress in understanding basic logy to every main disease area. In the NIH, $944M immune mechanisms is essential for developing the National Institute of Allergy and Infectious $406M $646M Nature Publishing Group Group Nature Publishing new abilities to treat and prevent diseases that Diseases (NIAID) oversees the largest portion 7 affect millions worldwide. Although federal of research on basic immunology and immune 1999 2003 2005 200 support for biomedical research has increased responses related to infectious and immune- Fiscal year © considerably over the past decade, funding has mediated diseases. Over the past decade, the Figure 1 Spending on immunology has continued remained flat over the past 3 years, leading to a NIH overall budget has grown considerably, to grow considerably along with the overall budget decrease in ‘purchasing power’ in the face of a increasing from $11.9 billion in fiscal year of the NIAID. As the NIAID budget increased from biomedical research inflation of approximately (FY) 1996 to $28.5 billion in FY 2005. In the $1.6 billion ($1.6B) in FY 1999 to $4.4B in FY 3%. Those budgetary constraints arrive at a same interval, the NIAID budget has grown at 2005, the spending on immunology (red disc; M, time of progress and excitement in the field an even faster pace, making NIAID the second million) also more than doubled. of immunology. This commentary addresses largest NIH institute, with an overall budget certain select opportunities for immunology of $4.4 billion. research, along with the challenges of imple- At present, the NIAID appropriation falls immunology research. Given the importance menting a robust immunology research agenda into three approximately equal categories of the science of immunology to biodefense, in an era of fiscal constraint. aligned with the institute’s main mission areas: HIV-AIDS and other infectious diseases, the human immunodeficiency virus (HIV) and investment by NIAID in immunology research The role of the NIH AIDS; biodefense; and immunology and infec- has the potential to grow considerably. Substantial but by no means the only support tious diseases, a category that includes research for immunology research comes from the on basic immunology, immune-mediated dis- Investigator-initiated research National Institutes of Health (NIH). Most of eases, microbiology, and infectious diseases Advances in fundamental immunology remind not in the HIV-AIDS or biodefense categories. us that the most important breakthroughs Although most immunology research has tra- in biomedical science generally have been Charles J. Hackett, Daniel Rotrosen, Hugh ditionally been supported by the appropriation achieved through the open-ended enquiry Auchincloss and Anthony S. Fauci are with the for immunology and infectious diseases, the that is the hallmark of investigator-initiated National Institute of Allergy and Infectious Diseases, discipline of immunology has also received research. Basic immunology research also pro- National Institutes of Health, Department of Health support from HIV-AIDS and biodefense vides the critical discoveries and mechanistic and Human Services, Bethesda, Maryland 20892, appropriations (Fig. 1). In FY 2005, the latest insights to underpin targeted programs that USA. year for which final figures are available, the address a growing expectation on the part of e-mail: [email protected] NIAID allocated more than $940 million to the administration, Congress and the general 114 VOLUME 8 NUMBER 2 FEBRUARY 2007 NATURE IMMUNOLOGY COMMENTARY public for concrete health-related advances in almost any biological molecule5. Harnessing molecules and antigen presentation mediated the form of ‘deliverables’,or products that can new knowledge about immune system func- by major histocompatibility complex class II be used to diagnose, prevent or treat disease.A tion is leading to ever-increasing capabilities molecules. Based on those principles, a grow- more detailed breakdown of NIAID spending to prevent or treat immune-mediated and ing list of adjuvant candidates now promises shows that growth in immunology research infectious diseases. However, even the consid- to provide improved vaccine immunogenicity occurred in several funding categories, with erable capacity of the immune system can be and reduced nonspecific reactivity while taking the largest continuing to be investigator-ini- overwhelmed by organisms naturally adapted advantage of the ability of the innate immune tiated research, which includes grants such as for virulence and immune evasion. For exam- system to channel adaptive immunity toward the individual R01, the exploratory or develop- ple, poxviruses, which include the smallpox the type of antibody or cellular responses most mental R21, small R03 and 1-year R56 bridge agent Variola major, may devote as many as appropriate for the control of a particular awards. Together these grants account for one half of their genes to virus-host interac- pathogen15. about 70% of all NIAID immunology research tions6. Understanding of the complexities of Immune tolerance holds the key to control- spending. Historically, solicited and unsolic- the scope of interactions between microbes and ling unwanted immunological attacks on self ited research programs typically have grown the immune system is just beginning. and transplanted tissues.Alloreactive responses in line with the overall budgetary growth of Although innate immunity is the most to transplanted tissues and organs have long the institute, with occasional deviations from ancient form of host defense, it is a key area been recognized as among the most powerful that general trend to address the urgent needs of discovery in contemporary immunology. known in immunology, being at least 100-fold of emerging research areas or the requirements The first ‘cluster of differentiation’ molecule, greater than those elicited by conventional for advanced development of medical coun- CD1, was identified in 1979 (ref. 7); however, antigens; such responses require potent, non- termeasures such as diagnostics, vaccines and more than 15 years passed before its function specific immunosuppression to maintain organ therapeutics. For example, solicited research as as a lipid antigen-presenting molecule in both allografts in clinical practice. In contrast, auto- a fraction of the NIAID immunology research innate and adaptive immunity was estab- immune diseases involve the loss of tolerance portfolio grew from about 20% in FY 1999 to lished8.At present,the field of innate immunity to self antigens. The identification of genes http://www.nature.com/natureimmunology about 30% in FY 2005, due mainly to biode- is moving rapidly and is providing the molec- involved in the establishment and maintenance fense contracts. ular basis for addressing decades-old ques- of central and peripheral tolerance provides a Nonetheless, we remain steadfastly con- tions concerning host defense mechanisms. new level of understanding and, potentially, vinced that it is the ingenuity of individual For example, although the function of type 1 control of deleterious immune responses. For scientists, expressed through investigator-ini- interferon responses to viral infection has been example, induction of central T cell tolerance tiated research, that will drive future discovery appreciated since 1957 (ref. 9), understanding is promoted by thymic expression of periph- in immunology, as in most areas of biomedical of the triggering of interferon synthesis was ill eral antigens related to the function of the gene science. That principle is broadly supported in defined until studies showed it to be based, for encoding the transcription factor Aire16. In the the scientific community, as demonstrated by many viruses, on cellular recognition of viral peripheral tissues, active antigen-specific sup- editorials and commentaries in the scientific single-stranded or double-stranded RNA. The pression mediated by a variety of T cells has 1 Nature Publishing Group Group Nature Publishing press and by the recommendations of many innate immune system casts a wide net for been repeatedly and reliably observed over 7 focus groups and expert panels convened by viral RNA, including the endosomal recep- decades. The association of the gene encoding 200 the NIAID (http://www.niaid.nih.gov/pub- tors TLR3 (which recognizes double-stranded the transcription factor Foxp3 with immune © lications/). Such discussions, including our RNA) and TLR7 and TLR8 (which recognize disorders and the linking of that gene to regula- ongoing dialog with academic and
Load more

Recommended publications
  • Germ-Line Regulation of the Caenorhabditis Elegans Sex-Determining Gene Tra-2
    DEVELOPMENTAL BIOLOGY 204, 251–262 (1998) ARTICLE NO. DB989062 Germ-Line Regulation of the Caenorhabditis elegans Sex-Determining Gene tra-2 Patricia E. Kuwabara,* Peter G. Okkema,† and Judith Kimble‡ *MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom; †Laboratory for Molecular Biology, University of Illinois at Chicago, Chicago, Illinois 60607; and ‡Howard Hughes Medical Institute, Laboratory of Molecular Biology, Department of Biochemistry, and Department of Medical Genetics, University of Wisconsin, Madison, Wisconsin 53706 The Caenorhabditis elegans sex-determining gene tra-2 promotes female development of the XX hermaphrodite soma and germ line. We previously showed that a 4.7-kb tra-2 mRNA, which encodes the membrane protein TRA-2A, provides the primary feminizing activity of the tra-2 locus. This paper focuses on the germ-line activity and regulation of tra-2. First, we characterize a 1.8-kb tra-2 mRNA, which is hermaphrodite-specific and germ-line-dependent. This mRNA encodes TRA-2B, a protein identical to a predicted intracellular domain of TRA-2A. We show that the 1.8-kb mRNA is oocyte-specific, suggesting that it is involved in germ-line or embryonic sex determination. Second, we identify a tra-2 maternal effect on brood size that may be associated with the 1.8-kb mRNA. Third, we investigate seven dominant tra-2(mx) (for mixed character) mutations that sexually transform hermaphrodites to females by eliminating hermaphrodite spermatogenesis. Each of the tra-2(mx) mutants possesses a nonconserved missense change in a 22-amino-acid region common to both TRA-2A and TRA-2B, called the MX region.
    [Show full text]
  • And Crry, the Two Genetic Homologues of Human CR1 by Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Disfin_ct Receptor and Regulatory Properties of Recombinant Mouse Complement Receptor 1 (CR1) and Crry, the Two Genetic Homologues of Human CR1 By Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V. Michael Holers* From the *Howard Hughes Medical Institute Laboratories and Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110; the *BASF Bioresearch Corporation, Cambridge, Massachusetts 02139; and the SDepartraent of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka 565, Japan Summary The relationship between the characterized mouse regulators of complement activation (RCA) genes and the 190-kD mouse complement receptor 1 (MCK1), 155-kD mouse complement receptor 2 (MCR2), and mouse p65 is unclear. One mouse RCA gene, designatedMCR2 (or Cr2), encodes alternatively spliced 21 and 15 short consensus repeat (SCR)-containing transcripts that crosshybridize with cDNAs of both human CR2 and CR1, or CR2 alone, respectively. A five SCR-containing transcript derived from a second unique gene, designated Crry, also crosshybridizes with human CR1. We have previously shown that the 155-kD MCR2 is encoded by the 15 SCR-containing transcript. To analyze the protein products of the other transcripts, which are considered the genetic homologues of human CRI, we have expressed the 21 and the 5 SCR-containing cDNAs in the human K562 erythroleukemia cell line. We demonstrate that cells expressing the 21 SCK transcript express the 190-kD MCR1 protein. These cells react with five unique rat anti-MCR1 monodonal antibodies, including the 8C12 antibody considered to be monospecific for MCK1.
    [Show full text]
  • Cd79a Percp-Cy5.5 Noto Anche Come: Mb-1 Catalog Number(S): 9045-0792-025 (25 Tests), 9045-0792-120 (120 Tests)
    Page 1 of 2 CD79a PerCP-Cy5.5 Noto anche come: mb-1 Catalog Number(s): 9045-0792-025 (25 tests), 9045-0792-120 (120 tests) Profili di fluorescenza di normali linfociti del sangue periferico umano non colorati (istogramma blu) o colorati a livello intracellulare con CD79a coniugati con PerCP-Cy5.5 (istogramma viola). Informazioni sul prodotto Indice: CD79a PerCP-Cy5.5 Storage Conditions: Conservare a 2-8 °C. Catalog Number(s): 9045-0792-025 (25 tests), Non congelare. 9045-0792-120 (120 tests) Materiale fotosensibile. Clone: HM47 Attenzione: contiene azide Concentrazione: 5 µl (0,03 µg)/test (un test viene Manufacturer: eBioscience, Inc., 10255 Science definito come la quantità in grado di colorare Center Drive, San Diego, CA 92121, USA 1x10e6 cellule in 100 μl) Authorized Representative: Bender MedSystems Ospite/isotipo: IgG1 di topo, kappa GmbH, an eBioscience Company Campus Vienna Workshop HLDA: V Biocenter 2 A-1030 Vienna Austria Formulazione: Tampone acquoso, 0,09% di sodio azide; può contenere proteina carrier/stabilizzante. Uso previsto Descrizione L'anticorpo monoclonale HM47 coniugato con fluorocromo L'anticorpo monoclonale HM47 riconosce il dominio reagisce con l'antigene CD79a umano. Il CD79a può essere citoplasmatico del CD79a, chiamato anche mb-1. Il CD79a è rilevato in campioni biologici umani mediante tecniche una glicoproteina di membrana da 47 kDa che si unisce al immunologiche. CD79b con cui forma il recettore eterodimerico per i linfociti Principi del test B (BCR). Questo recettore è responsabile della segnalazione La citometria a flusso è uno strumento utile per la misurazione dei linfociti B e causa la loro attivazione, apoptosi o anergia.
    [Show full text]
  • Research Article Microarray Analysis of the Molecular Mechanism Involved in Parkinson’S Disease
    Hindawi Parkinson’s Disease Volume 2018, Article ID 1590465, 12 pages https://doi.org/10.1155/2018/1590465 Research Article Microarray Analysis of the Molecular Mechanism Involved in Parkinson’s Disease Cheng Tan, Xiaoyang Liu, and Jiajun Chen Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China Correspondence should be addressed to Jiajun Chen; [email protected] Received 24 May 2017; Revised 21 August 2017; Accepted 18 October 2017; Published 1 March 2018 Academic Editor: Amnon Sintov Copyright © 2018 Cheng Tan et al. )is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Purpose. )is study aimed to investigate the underlying molecular mechanisms of Parkinson’s disease (PD) by bioinformatics. Methods. Using the microarray dataset GSE72267 from the Gene Expression Omnibus database, which included 40 blood samples from PD patients and 19 matched controls, differentially expressed genes (DEGs) were identified after data preprocessing, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Protein-protein interaction (PPI) network, microRNA- (miRNA-) target regulatory network, and transcription factor- (TF-) target regulatory networks were constructed. Results. Of 819 DEGs obtained, 359 were upregulated and 460 were downregulated. Two GO terms, “rRNA processing” and “cytoplasm,” and two KEGG pathways, “metabolic pathways” and “TNF signaling pathway,” played roles in PD development. Intercellular adhesion molecule 1 (ICAM1) was the hub node in the PPI network; hsa- miR-7-5p, hsa-miR-433-3p, and hsa-miR-133b participated in PD pathogenesis.
    [Show full text]
  • Analyzing the Phenotypic and Functional Complexity of Lymphocytes Using Cytof (Cytometry by Time-Of-Flight)
    Cellular & Molecular Immunology (2012) 9, 322–323 ß 2012 CSI and USTC. All rights reserved 1672-7681/12 $32.00 www.nature.com/cmi RESEARCH HIGHLIGHT Analyzing the phenotypic and functional complexity of lymphocytes using CyTOF (cytometry by time-of-flight) Guobing Chen and Nan-ping Weng Cellular & Molecular Immunology (2012) 9, 322–323; doi:10.1038/cmi.2012.16; published online 28 May 2012 he human immune system is equipped antigen peptide-MHC tetramers on human status of cytokines, cytotoxic granule T with vast numbers of lymphocytes pos- CD81 T cells. These parameters covered components and CD107, a degranulation sessing distinct antigen specificities. The nine functional attributes and distinguished marker. A shift in the proportions of enormous repertoire and heterogeneity of all reported CD81 T-cell subsets, such as cells with each phenotype was identified after lymphocytes ensures their ability to effec- naive, central memory, effector memory, in vitro stimulation with either PMA/ tively fight against external microbial inva- terminal effector, long-lived memory pre- ionomycin or anti-CD36anti-CD28. PMA/ ders, as well as internal aberrant cells. cursor effector cells and short-lived effector ionomycin induced a greater number of dis- However, the understanding of the specific cells. The authors used principal compon- tinct functional types of CD81 T cells than phenotypes and functions of lymphocytes is ent analysis (PCA) to analyze the large did anti-CD36anti-CD28. However, because hindered by the lack of tools that can be used CyTOF datasets and presented their results these studies were performed at the same to visualize this complexity. Fluorescent dye- either in two-dimensional PCA or in com- timepoint after stimulation, it is not clear based flow cytometry, which can simulta- bination with a protein structure program whether the observed difference in the num- 1 neously analyze 8–10 parameters of a single (PyMOL) as three-dimensional PCA.
    [Show full text]
  • A Possible Approach for Oral Drug Delivery of Nanoparticles
    COSMOS, Vol. 10, No. 1 (2014) 1–4 © World Scienti¯c Publishing Company DOI: 10.1142/S0219607714400035 A POSSIBLE APPROACH FOR ORAL DRUG DELIVERY OF NANOPARTICLES RABI'ATUL `ADAWIYAH BINTE MINHAT and THILO HAGEN Department of Biochemistry, Yong Loo Lin School of Medicine National University of Singapore, 117599 Singapore Received 12 February 2014 Revised 26 March 2014 Accepted 10 April 2014 Published 13 February 2015 Keywords: Oral drug delivery; nanoparticles; neonatal Fc receptor. Advances in biotechnology have led to numerous nanoparticles relative to the total atom number.2 discoveries and development of proteins and other These special properties are the reason why nano- macromolecules as pharmaceutical drugs.2 The particles have a wide variety of potential applica- production of macromolecules as therapeutics has tions in various ¯elds such as medicine, energy and improved treatment options in many areas in electronics industries. Thus, the development of an medicine. However, delivery of these macromolecule oral delivery system using nanoparticles is advan- COSMOS Downloaded from www.worldscientific.com drugs has mostly been restricted to parenteral tageous. If successful, the method could be combined methods of administration. The development of a with other techniques, such as a nanoparticle-based more convenient oral delivery system still faces many chemotherapy free of the debilitating side-e®ects,7,9 challenges. to further improve available treatment options. by NATIONAL UNIVERSITY OF SINGAPORE on 03/30/15. For personal use only. Many macromolecule drugs are vulnerable to the There have been several attempts to develop a pH variation and enzymatic degradation in the method for oral drug delivery using nanoparticles,2 gastrointestinal tract.2 One way to protect the drugs but these attempts have mostly had undesirable from degradation is by encapsulation.4 In particular, drawbacks.
    [Show full text]
  • A Role for the L-Selectin Adhesion System in Mediating Cytotrophoblast Emigration from the Placenta
    Developmental Biology 298 (2006) 107–117 www.elsevier.com/locate/ydbio A role for the L-selectin adhesion system in mediating cytotrophoblast emigration from the placenta ⁎ Akraporn Prakobphol a, Olga Genbacev a, Matthew Gormley a, Mirhan Kapidzic a, Susan J. Fisher a,b, a Department of Cell and Tissue Biology, University of California, San Francisco, CA 94143, USA b Departments of Anatomy and Pharmaceutical Chemistry, University of California, San Francisco, CA 94143, USA Received for publication 24 February 2006; revised 13 June 2006; accepted 13 June 2006 Available online 15 June 2006 Abstract Cytotrophoblast (CTB) aggregates that bridge the gap between the placenta and the uterus are suspended as cell columns in the intervillous space, where they experience significant amounts of shear stress generated by maternal blood flow. The proper formation of these structures is crucial to pregnancy outcome as they play a vital role in anchoring the embryo/fetus to the decidua. At the same time, they provide a route by which CTBs enter the uterine wall. The mechanism by which the integrity of the columns is maintained while allowing cell movement is unknown. Here, we present evidence that the interactions of L-selectin with its carbohydrate ligands, a specialized adhesion system that is activated by shear stress, play an important role. CTBs in cell columns, particularly near the distal ends, stained brightly for L-selectin and with the TRA-1-81 antibody, which recognizes carbohydrate epitopes that support binding of L-selectin chimeras in vitro. Function-perturbing antibodies that inhibited either receptor or ligand activity also inhibited formation of cell columns in vitro.
    [Show full text]
  • (CR1) and Crry, the Two Genetic Homologues of Human CR1 by Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V
    Disfin_ct Receptor and Regulatory Properties of Recombinant Mouse Complement Receptor 1 (CR1) and Crry, the Two Genetic Homologues of Human CR1 By Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V. Michael Holers* From the *Howard Hughes Medical Institute Laboratories and Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110; the *BASF Bioresearch Corporation, Cambridge, Massachusetts 02139; and the SDepartraent of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka 565, Japan Downloaded from http://rupress.org/jem/article-pdf/175/1/121/1267946/121.pdf by guest on 27 September 2021 Summary The relationship between the characterized mouse regulators of complement activation (RCA) genes and the 190-kD mouse complement receptor 1 (MCK1), 155-kD mouse complement receptor 2 (MCR2), and mouse p65 is unclear. One mouse RCA gene, designatedMCR2 (or Cr2), encodes alternatively spliced 21 and 15 short consensus repeat (SCR)-containing transcripts that crosshybridize with cDNAs of both human CR2 and CR1, or CR2 alone, respectively. A five SCR-containing transcript derived from a second unique gene, designated Crry, also crosshybridizes with human CR1. We have previously shown that the 155-kD MCR2 is encoded by the 15 SCR-containing transcript. To analyze the protein products of the other transcripts, which are considered the genetic homologues of human CRI, we have expressed the 21 and the 5 SCR-containing cDNAs in the human K562 erythroleukemia cell line. We demonstrate that cells expressing the 21 SCK transcript express the 190-kD MCR1 protein. These cells react with five unique rat anti-MCR1 monodonal antibodies, including the 8C12 antibody considered to be monospecific for MCK1.
    [Show full text]
  • Download Slides
    PEARLS OF LABORATORY MEDICINE Pearl Title: Immunoglobulin and T Cell Receptor Genetics Name of Presenter: Bing Melody Zhang Affiliation: Stanford University School of Medicine DOI: 10.15428/CCTC.2020.318055 © Clinical Chemistry Outline • Structure of Immunoglobulin (Ig) and TCR (T cell receptor) • TCR/Ig genetics • T/B cell development and TCR/Ig gene rearrangement • Molecular testing of TCR/Ig rearrangement • Clinical utility of molecular TCR/Ig rearrangement analysis in lymphoid malignancies 2 Immunoglobulin (Ig) and T Cell Receptor (TCR) 3 TCR/Ig Genetics • Each receptor chain is encoded in the germline genome as different gene segments (V, D, J). • During T/B lymphocyte development, the gene segments undergo random somatic DNA recombination (VDJ or VJ) to form a complete variable region sequence, known as gene rearrangement. • Non-templated insertion and deletion of random nucleotides at the junctional regions. • Somatic hypermutation: high rate of point mutations in V region of Ig genes (mature B cells). 4 IGH Gene Rearrangement V genes D genes J genes Constant region Germline V-N-D-N-J 5 B cell development and BCR/Ig gene rearrangement Large pre- Small pre- Immature B Mature B Stem cells Early pro-B Late pro-B cell cell B cell B cell cell cell IgH: germline D-J joining V-DJ joining VDJ rearranged VDJ rearranged VDJ rearranged VDJ rearranged IgK/L: germline germline germline germline V-J joining VJ rearranged VJ rearranged Order of gene rearrangements: IGH → IGK If IGK rearrangement fails → IGL gene rearrangement The Immune System,
    [Show full text]
  • Inventories of Naive and Tolerant Mouse CD4 T Cell Repertoires Reveal a Hierarchy of Deleted and Diverted T Cell Receptors
    Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptors Tobias Hasslera, Emanuel Urmanna, Sebastian Teschnera, Christine Federlea, Thamotharampillai Dileepanb, Kilian Schoberc, Marc K. Jenkinsb, Dirk H. Buschc,d, Maria Hinterbergera,1, and Ludger Kleina,1,2 aInstitute for Immunology, Faculty of Medicine, Ludwig-Maximilians-University, 82152 Planegg-Martinsried, Germany; bCenter for Immunology, University of Minnesota, Minneapolis, MN 55455; cInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 Munich, Germany; and dGerman Center for Infection Research, 81675 Munich, Germany Edited by Shimon Sakaguchi, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan, and approved August 5, 2019 (received for review May 2, 2019) – Deletion or Treg cell differentiation are alternative fates of autore- deletional tolerance (14 17), also shapes the Treg cell repertoire active MHCII-restricted thymocytes. How these different modes (18–20). of tolerance determine the size and composition of polyclonal co- MHCII tetramers were employed to trace minute cohorts of horts of autoreactive T cells with shared specificity is poorly un- CD4 T cells when their cognate antigens were transgenically derstood. We addressed how tolerance to a naturally expressed expressed to emulate a ubiquitous or TRA-like expression pat- autoantigen of the central nervous system shapes the CD4 T cell tern (21, 22). Widespread antigen expression was associated with repertoire. Specific cells in the tolerant peripheral repertoire either deletion, whereas a more restricted TRA-like expression ensued + + were Foxp3 or displayed anergy hallmarks and, surprisingly, in the emergence of Foxp3 Treg cells. While these findings were at least as frequent as in the nontolerant repertoire.
    [Show full text]
  • TITLE: Immunoglobulin and T Cell Receptor Genetics PRESENTER: Bing Melody Zhang
    TITLE: Immunoglobulin and T Cell Receptor Genetics PRESENTER: Bing Melody Zhang Slide 1: Hello, my name is Bing Melody Zhang. I am an Assistant professor (Clinical) of Pathology at Stanford University. Welcome to this Pearl of Laboratory Medicine on “Immunoglobulin and T Cell Receptor Genetics.” Slide 2: Here is the outline of this talk. I will cover the structure and genetics of Ig and TCR, T/B cell development and TCR/Ig gene rearrangements, molecular testing and clinical utility of TCR/Ig rearrangement analysis. Slide 3: Let’s first review the structure of Ig and TCR. B and T lymphocytes are characterized by their antigen-specific receptors, which are the primary effector molecules of the adaptive immune system. For B cells, there are the membrane-bound form of the immunoglobulin as main component of the B cell receptor (BCR), and the soluble form of Ig secreted by plasma cells. Both forms of Ig have the identical Y- shaped structure, composed of 2 heavy and 2 light chains. © 2016 Clinical Chemistry Pearls of Laboratory Medicine Title On the other hand, T cell receptors are heterodimeric cell surface molecules responsible for recognizing antigens presented to T cells in context of MHC molecules. In the circulation, majority (95%) of T cells express alpha beta chains and a minority of T cells express gamma- delta chains, as part of the TCR complex. Gamma-delta T cells are dominant subtype of T cells found in epithelial tissues. Both TCR and Ig molecules consist of variable and constant regions. Each lymphocyte receptor has a unique antigen-specificity determined by the structure of antigen-binding site primarily from the variable amino acid sequences.
    [Show full text]
  • Cells of the Immune System and Innate Immunity
    Harvard-MIT Division of Health Sciences and Technology HST.176: Cellular and Molecular Immunology Course Director: Dr. Shiv Pillai Cells of the Immune System and Innate Immunity Recommended reading: Abbas et al., 4th edition, Chapters 2 and 12 Janeway and Travers, 5th edition, Chapters 1 and 10 The innate immune system is made up of molecules and cellular processes that defend the host within minutes and hours after exposure to a noxious stimulus. It is the only immune system in plants and invertebrates. Innate immune responses may initiate acute inflammation, which basically involves the accumulation and activation of phagocytes (mainly polymorphonuclear cells in man) and of vascular endothelium at sites of injury. In vertebrates, the innate and adaptive immune systems talk to each other and there is an important reciprocal interplay that operates between these systems. In these animals the cells and molecules of the innate immune system provide immediate protection and then set in motion the activation of the adaptive immune response. The adaptive immune response in turn “revs” up innate immune mechanisms of host defense. The innate immune system uses non-clonal “pattern recognition” receptors (PRRs) which cannot recognize host structures but which do recognize patterns found on microbes.These are sometimes called PAMPs for Pathogen Associated Molecular Patterns. Pathogens/ microbes The most common organisms that cause disease are viruses, bacteria, fungi, protozoa, and worms. A microbe (a small invader) or a worm that does not cause disease in most people may generally be classified as non-pathogenic. Such an organism will provoke an immune response in a normal immunocompetent host.
    [Show full text]